Background Image
Previous Page  130 / 156 Next Page
Information
Show Menu
Previous Page 130 / 156 Next Page
Page Background

128

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

43

Cappelli C, Reale G, Marucci G, Clerico A. [Transdermal fentanyl: a new tool for pain

therapy in pediatric oncology]. Clin Ter 2008; 159(4): 257-260.

44

Carroll EM, Kamboj SK, Conroy L, Tookman A, Williams AC, Jones L, Morgan CJ, Curran

HV. Facial affect processing in patients receiving opioid treatment in palliative care:

preferential processing of threat in pain catastrophizers. J Pain Symptom Manage 2011;

41(6): 975-985.

45

Cepeda MS, Carr DB, Lau J, Alvarez H. Music for pain relief. Cochrane Database Syst Rev

2006; (2): CD004843.

46

Chan SK, Lai PB, Li PT, Wong J, Karmakar MK, Lee KF, Gin T. The analgesic efficacy of conti-

nuous wound instillation with ropivacaine after open hepatic surgery. Anaesthesia 2010;

65(12): 1180-1186.

47

Chang JT, Lin CY, Lin JC, Lee MS, Chen YJ, Wang HM. Transdermal fentanyl for pain caused

by radiotherapy in head and neck cancer patients treated in an outpatient setting: a

multicenter trial in Taiwan. Jpn J Clin Oncol 2010; 40(4): 307-312.

48

Chou WY, Wang CH, Liu PH, Liu CC, Tseng CC, Jawan B. Human opioid receptor A118G

polymorphism affects intravenous patient-controlled analgesia morphine consumption

after total abdominal hysterectomy. Anesthesiology 2006; 105(2): 334-337.

49

Clemens KE, Klaschik E. Effect of hydromorphone on ventilation in palliative care patients

with dyspnea. Support Care Cancer 2008; 16(1): 93-99.

50

Colella J, Scrofine S, Galli B, Knorr-Mulder C, Gejerman G, Scheuch J, Lanteri V, Siegel A,

Levey S, Watson R, Block M, Sawczuk I. Prostate HDR radiation therapy: a comparative

study evaluating the effectiveness of pain management with peripheral PCA vs. PCEA.

Urol Nurs 2006; 26(1): 57-61.

51

Colombani S, Kabbani Y, Mathoulin-Pélissier S, Gékière JP, Dixmérias F, Monnin D, Lakdja

F [Administration of ketamine during induction and maintenance of anaesthesia in post-

operative pain prevention]. Ann Fr Anesth Reanim 2008; 27(3): 202-207.

52

Corso OH, Morris RG, Hewett PJ, Karatassas A. Safety of 96-hour incision-site continuous

infusion of ropivacaine for postoperative analgesia after bowel cancer resection. Ther

Drug Monit 2007; 29(1): 57-63.

53

Costa L, Major PP. Effect of bisphosphonates on pain and quality of life in patients with

bone metastases (Review). Nature Clinical Practice 2009; Oncology 6 (3), 163-174.

54

Cubero DI, del GA. Early switching from morphine to methadone is not improved by

acetaminophen in the analgesia of oncologic patients: a prospective, randomized,

double-blind, placebo-controlled study. Support Care Cancer 2010; 18(2): 235-242.

55

Currow DC, Plummer JL, Cooney NJ, Gorman D, Glare PA. A randomized, double-blind,

multi-site, crossover, placebo-controlled equivalence study of morning versus evening

once-daily sustained-release morphine sulfate in people with pain from advanced cancer.

J Pain Symptom Manage 2007; 34(1): 17-23.

56

Dagtekin O, Hotz A, Kampe S, Auweiler M, Warm M. Postoperative analgesia and flap

perfusion after pedicled TRAM flap reconstruction - continuous wound instillation with

ropivacaine 0.2%. A pilot study. J Plast Reconstr Aesthet Surg 2009; 62(5): 618-625.

Literaturverzeichnis